Donor- and patient-derived interleukin 6 knockdown CD19-targeted chimeric antigen receptor T cells exhibit similar efficacy and safety in treating relapsed B-cell acute lymphoblastic leukemia patients after allogeneic hematopoietic stem cell transplantation

Cytotherapy 2026

View at publisher
Authors: Ting Sun, Jinfeng Ma, Xu Jia, Shun-Zhe Xu, Shen-Hao Liu, Xiaoyu Lyu, Si‐Man Huang, Yan-Jun Wu, Zhen Yao, Chongsheng Qian, Zheng Li, Lei Yu
+3 more Haiping Dai, Wenjie Gong, Sheng-Li Xue
DOI: 10.1016/j.jcyt.2026.102118
Cited by: 0
References: 14

Fields of Study & Subjects

CAR-T cell therapy research Acute Lymphoblastic Leukemia research T-cell and B-cell Immunology

Publication details

Journal / source
Cytotherapy
Volume
28
Issue
6
Pages
102118–102118
Publication date
16 February 2026
Language
EN